Sonia Okuyama

Has grant

Division Chief, Hematology and Oncology

Denver Health & Hospital Authority

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sonia Okuyama is the Division Chief of Hematology and Oncology at Denver Health & Hospital Authority in the United States. Her research primarily focuses on cancer genetic testing and its implications for underserved populations, as demonstrated in her recent articles regarding mental health outcomes in cancer patients and the integration of genetic services in safety net systems. She is dedicated to improving access to cancer care and enhancing patient outcomes through innovative research in genomics and risk assessment.

Recent Grants

Grant: Open

Applying Population Management Best Practices to Preventive Genomic Medicine

Open Date: 2023-05-10

Close Date: 2028-02-29

Grant: Close

Exome sequencing in Diverse Populations in Colorado & Oregon

Open Date: 2013-06-14

Close Date: 2023-05-31

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (3)

Kathleen F. Mittendorf

UNITED STATES

View details

Brian H. Shirts

UNITED STATES

View details

Stephanie Kraft

Washington University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sonia Okuyama

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study

Stepped-care to improve mental health outcomes among underserved patients with lung and head and neck cancer.

Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system.

Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project

Risk‐reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system

Engaging Patient Advisory Committees to Inform a Genomic Cancer Risk Study: Lessons for Future Efforts.

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population

Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access.

Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations

Examining access to care in clinical genomic research and medicine: Experiences from the CSER Consortium.

Collaborators (3)

Kathleen F. Mittendorf

Brian H. Shirts

Stephanie Kraft

Make your next move.